0001104659-21-002795.txt : 20210111 0001104659-21-002795.hdr.sgml : 20210111 20210111093041 ACCESSION NUMBER: 0001104659-21-002795 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Renstrup Jens CENTRAL INDEX KEY: 0001786967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 21519573 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC. STREET 2: 100 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2022926-12_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-01-07 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001786967 Renstrup Jens C/O SPRINGWORKS THERAPEUTICS, INC., 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Medical Officer Common Stock 2021-01-07 4 A 0 6075 0 A 250499 D Stock Option (Right to Buy) 70.68 2021-01-07 4 A 0 48600 0 A 2031-01-07 Common Stock 48600 48600 D Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on January 7, 2022, another thirty three percent (33%) to vest on January 7, 2023 and the remaining thirty four percent (34%) to vest on January 7, 2024, such that the restricted stock awards are fully vested on January 7, 2024. svThis option shall vest in 48 equal monthly installments subject to continued service to the Company by the Reporting Person. /s/ Francis I. Perier, Jr as Attorney-in-Fact 2021-01-11